Ibrutinib Enhances the Efficacy of ROR1 Bispecific T Cell Engager Mediated Cytotoxicity in Chronic Lymphocytic Leukaemia
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15911
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 7, 2019
Authors
Publisher
Wiley